亚太地区高度活跃的 API 市场 - 分析与预测（2023-2033）

亚太地区高度活跃的 API 市场规模预计将从 2023 年的 74.9 亿美元增至 2033 年的 256.8 亿美元，2023-2033 年的复合年增长率为 13.11%。

癌症盛行率的增加正在推动对高活性 API 的需求，而这些高活性 API 在各种医疗疾病中的治疗应用的扩大是推动亚太地区高活性 API 市场成长的关键因素。

由于慢性病的流行和对标靶治疗的需求不断增长，亚太地区高活性药物成分（HPAPI）市场正在迅速扩大。 HPAPI 在创造高效药物方面发挥着重要作用，特别是在治疗荷尔蒙失衡、癌症和某些其他医疗状况方面。由于该地区製药业的发展以及製造能力和技术的提高，市场正在不断扩大。

这种扩张是由受益于强大的基础设施、技术纯熟劳工和促进成长的法律体制的国家主导的。此外，受託製造厂商（CMO）的成长和研发投资的增加进一步增加了市场潜力。

本报告研究了亚太地区高活跃 API 市场，提供了特定国家的趋势和进入市场的公司概况。

目录

执行摘要

第一章 市场

• 趋势：当前和未来的影响评估
• 供应链/价值概述
• 价格分析
• 专利申请趋势（按年份、按国家）
• 监管状况
• 全球重大事件的影响分析 - COVID-19
• 市场动态：概述

第二章 区域

• 区域概况
• 亚太地区

第三章市场－竞争基准化分析与公司概况

• 未来展望
• 地理评估
  • Asymchem Inc.
  • Dr. Reddy's Laboratories Ltd.
  • CARBOGEN AMCIS

第四章调查方法

Introduction to Asia-Pacific (APAC) Highly Potent API Market

The Asia-Pacific highly potent API market is projected to reach $25.68 billion by 2033 from $7.49 billion in 2023, growing at a CAGR of 13.11% during the forecast period 2023-2033. The increasing prevalence of cancer is driving the demand for highly potent APIs, and the expanding therapeutic applications of these potent APIs across a range of medical disorders are the main factors driving the growth of the APAC extremely potent API market.

Market Introduction

The market for highly potent active pharmaceutical ingredients (HPAPI) in Asia-Pacific is expanding quickly due to the growing prevalence of chronic illnesses and the growing need for targeted therapeutics. HPAPIs play a crucial role in the creation of extremely potent drugs, especially in the treatment of hormone imbalances, cancer, and other specific medical conditions. The market is growing thanks to the region's developing pharmaceutical industry, as well as improvements in manufacturing capacity and technology.

Leading the way in this expansion are nations which gain from strong infrastructure, highly skilled workers, and legislative frameworks that encourage growth. Additionally, the market's potential is being further enhanced by the growth of contract manufacturing organizations (CMOs) and greater investment in research and development. This research explores the APAC HPAPI market's future trends, key players, regulatory landscape, and current market dynamics, offering insightful information to stakeholders hoping to take advantage of new business possibilities in this rapidly expanding industry.

Market Segmentation

Segmentation 1: by Region

• China
• Japan
• India
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Competitive Strategy: The Asia-Pacific highly potent API market has numerous established players with product and service portfolios. Key players in the Asia-Pacific highly potent API market analysed and profiled in the study involve established players offering product and services of highly potent API.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

• Asymchem Inc.
• Dr. Reddy's Laboratories Ltd.
• CARBOGEN AMCIS

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Trend 1: Advancements in Containment Technologies for Highly Potent APIs
  • 1.1.2 Trend 2: Increasing Investment for Highly Potent API Manufacturing Units
  • 1.1.3 Trend 3: Pharmaceutical Companies Outsourcing Highly Potent APIs Production to CDMOs
• 1.2 Supply Chain /Value Overview
  • 1.2.1 Supply Chain and Risks within the Supply Chain
  • 1.2.2 Value Chain Analysis
• 1.3 Pricing Analysis
• 1.4 Patent Filing Trend (by Year, Country)
• 1.5 Regulatory Landscape
• 1.6 Impact Analysis for Key Global Events - COVID-19
• 1.7 Market Dynamics: Overview
  • 1.7.1 Market Drivers
    • 1.7.1.1 Increasing Incidence of Cancer Leading to Demand in the Adoption of Highly Potent APIs
    • 1.7.1.2 Advancements in Drug Delivery Technologies
    • 1.7.1.3 Expanding Therapeutic Applications of Highly Potent API
  • 1.7.2 Market Opportunities
    • 1.7.2.1 Growing Emphasis on Personalized Medicine
    • 1.7.2.2 Increasing Opportunities for Pharma Companies in Developing Markets
  • 1.7.3 Market Restraints
    • 1.7.3.1 Regulatory Complexity for Highly Potent APIs' Manufacturing
    • 1.7.3.2 High Development and Production Costs

2 Regions

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Japan
  • 2.2.7 Australia
  • 2.2.8 South Korea
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets -Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Geographic Assessment
  • 3.2.1 Asymchem Inc.
    • 3.2.1.1 Overview
    • 3.2.1.2 Key Developments
    • 3.2.1.3 Top Products/Product/Service Portfolio
    • 3.2.1.4 Top Competitors
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 Dr. Reddy's Laboratories Ltd.
    • 3.2.2.1 Overview
    • 3.2.2.2 Key Developments
    • 3.2.2.3 Top Products/Product/Service Portfolio
    • 3.2.2.4 Top Competitors
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 CARBOGEN AMCIS
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products/Product/Service Portfolio
    • 3.2.3.3 Key Developments
    • 3.2.3.4 Top Competitors
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Highly Potent API Market, Recent Developments
• Figure 2: Highly Potent API Market: Value Chain Analysis
• Figure 3: Highly Potent API Market: Pricing Analysis
• Figure 4: Highly Potent API Market, Patent Analysis (by Year), January 2018-December 2023
• Figure 5: Highly Potent API Market, Patent Analysis (by Country), January 2018-December 2023
• Figure 6: Regulatory Framework for Highly Potent API
• Figure 7: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 8: Incidence of Cancer (by Region), Million, 2020-2040
• Figure 9: Asia-Pacific Highly Potent API Market, $Billion, 2022-2033
• Figure 10: China Highly Potent API Market, $Billion, 2022-2033
• Figure 11: India Highly Potent API Market, $Billion, 2022-2033
• Figure 12: Japan Highly Potent API Market, $Billion, 2022-2033
• Figure 13: Australia Highly Potent API Market, $Billion, 2022-2033
• Figure 14: South Korea Highly Potent API Market, $Billion, 2022-2033
• Figure 15: Rest-of-Asia-Pacific Highly Potent API Market, $Billion, 2022-2033
• Figure 16: Some of the Key Innovators in the Highly Potent API Landscape
• Figure 17: Highly Potent API Market: Geographical Assessment
• Figure 18: Strategic Initiatives, January 2021-December 2023
• Figure 19: Share of Strategic Initiatives
• Figure 20: Data Triangulation
• Figure 21: Top-Down and Bottom-Up Approach
• Figure 22: Assumptions and Limitations

List of Tables

• Table 1: Asia-Pacific Highly Potent API Market Snapshot
• Table 2: Short-Term and Long-Term Opportunities and Risks (by Region)
• Table 3: Key Trends, Impact Analysis
• Table 4: Highly Potent API Market, Key Investment
• Table 5: Recent Innovations for Manufacturing and Handling of Highly Potent Drugs
• Table 6: Highly Potent API Market (by Region), $Billion, 2022-2033
• Table 7: Highly Potent API Market (by Country), $Billion, 2022-2033